Mechanisms of Mineralocorticoid Action

Hypertension - Tập 46 Số 6 - Trang 1227-1235 - 2005
Peter J. Fuller1, Morag J. Young1
1From Prince Henry’s Institute of Medical Research, Clayton, Victoria, Australia.

Tóm tắt

Sodium transport in epithelial tissues is regulated by the physiological mineralocorticoid aldosterone. The response to aldosterone is mediated by the mineralocorticoid receptor (MR), for which the crystal structure of the ligand-binding domain has recently been established. The classical mode of action for this receptor involves the regulation of gene transcription. Several genes have now been shown to be regulated by aldosterone in epithelial tissues. Of these, the best characterized is serum- and glucocorticoid-regulated kinase, which increases sodium influx through the epithelial sodium channel. Turnover of these channels in the cell membrane is mediated by Nedd4–2, a ubiquitin protein ligase; serum- and glucocorticoid-regulated kinase interacts with and phosphorylates Nedd4–2, thereby rendering it unable to bind the sodium channels. In nonepithelial tissues, particularly the cardiovascular system, aldosterone also has direct effects, activating an inflammatory cascade, leading to cardiac fibrosis. A critical role for the MR in cardiovascular disease has now been demonstrated by the beneficial response to MR blockade in 2 large clinical trials in patients with cardiac failure. It is these nonepithelial actions of MR activation that need to be exploited for the development of antagonists that target the cardiovascular system while avoiding the undesirable side effects of renal MR blockade.

Từ khóa


Tài liệu tham khảo

10.1007/BF02155834

10.1016/S0092-8674(01)00241-0

10.1159/000075242

Selye H. The general adaptation syndrome and the diseases of adaptation. Practitioner. 1949; 163: 393–405.

10.1016/j.mce.2003.10.009

10.1038/nsmb939

10.1074/jbc.M504098200

10.1016/j.molcel.2005.06.026

10.1073/pnas.95.16.9424

10.1074/jbc.M100374200

10.1016/S0039-128X(99)00087-2

10.1126/science.3037703

10.1126/science.289.5476.119

10.1210/en.2002-220708

10.1016/j.tem.2004.07.001

10.1016/S1097-2765(04)00054-1

10.1677/jme.0.0310573

10.1111/j.1440-1681.2004.04079.x

10.1210/me.2005-0089

10.1016/S0303-7207(02)00413-6

10.1101/gad.14.2.121

10.1124/mol.65.3.761

10.1210/me.2004-0331

10.1128/MCB.22.11.3698-3706.2002

10.1210/me.2004-0537

10.1210/er.2002-0006

10.1006/abbi.2000.2045

McCormick JA, Bhalla V, Pao AC, Pearce D. SGK1: a rapid aldosterone-induced regulator of renal sodium reabsorption. Physiology. 2004; 20: 134–139.

10.1152/ajpregu.00369.2004

10.1097/01.ASN.0000061777.67332.77

10.1016/S0960-0760(03)00200-0

10.1016/S0303-7207(00)00274-4

10.1210/endo.142.4.8095

10.1074/jbc.M403260200

10.1152/ajprenal.00242.2004

10.1074/jbc.M212301200

10.1172/JCI0215696

10.1681/ASN.2004100828

10.1152/ajprenal.00320.2001

10.1016/j.mce.2003.10.021

10.1159/000076932

10.1093/emboj/20.15.3993

Robert-Nicoud M, Flahaut M, Elalouf JM, Nicod M, Salinas M, Bens M, Doucet A, Wincker P, Artiguenave F, Horisberger JD, Vandewalle A, Rossier BC, Firsov D. Transcriptome of a mouse kidney cortical collecting duct cell line: effects of aldosterone and vasopressin. Proc Natl Acad Sci U S A. 2001; 27: 2712–2716.

10.1074/jbc.M200272200

10.1046/j.1523-1755.2003.00216.x

10.1152/ajprenal.00353.2002

10.1056/NEJMoa040135

10.1152/ajpendo.1991.260.5.E719

10.1210/er.2005-0004

Zhu Y, Bond J, Thomas P. Identification, classification and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci U S A. 2002; 100: 2237–2242.

10.1126/science.1106943

10.1210/en.2004-1064

10.1016/S1043-2760(03)00027-4

10.1161/hyp.35.5.1099

10.1016/S0039-128X(01)00183-0

10.1006/bbrc.1999.1771

10.1152/ajprenal.00378.2003

10.1111/j.1365-201X.2004.01313.x

10.1210/en.2003-1137

Wehling M, Spes CH, Win N, Janson CP, Schmidt BMW, Theisen K, Christ M. Rapid cardiovascular action of aldosterone in man. J Clin Endocrinol Metab. 1998; 83: 3517–3522.

10.1152/japplphysiol.00572.2004

Brilla CG, Weber KT. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med. 1992; 120: 893–901.

10.1172/JCI117269

10.1152/ajpendo.1990.258.4.E649

10.1161/01.res.0000080521.15238.e5

Young M, Head G, Funder J. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am J Physiol. 1995; 269: E657–E662.

10.1210/en.2002-220926

10.1152/ajpheart.01096.2001

10.1016/S0002-9440(10)64454-9

10.1161/01.hyp.0000144466.11568.7e

10.1016/j.cardfail.2004.03.002

10.1210/endo.137.10.8828470

10.1161/circulationaha.104.503706

10.1016/j.cardiores.2005.05.009

10.1161/01.cir.0000121426.43044.2b

10.3346/jkms.2004.19.6.805

10.1016/j.mce.2005.03.016

10.1161/01.hyp.0000176236.55322.18

10.1210/en.2002-220956

10.1006/jmcc.1994.1098

10.1093/cvr/28.12.1863

10.1016/j.tem.2004.08.002

10.1161/01.hyp.0000174593.88899.68

10.1161/hyp.26.6.971

10.1073/pnas.102673599

10.1038/74914

10.1161/01.hyp.0000088855.06598.5b

10.1161/hyp.33.4.981

10.1016/0960-0760(94)00168-L

10.1161/01.hyp.0000088363.65943.6c

10.1152/ajpheart.00035.2003

10.1210/en.2003-0039

10.1161/01.hyp.0000172622.51973.f5

10.1161/01.res.0000180753.63183.95

10.1007/s10741-005-2344-2

10.1210/en.2004-0005

10.1161/circ.104.4.467

Thông tin
Thông tin xuất bản

Hypertension

Tập 46 Số 6

1227-1235

Thông tin tác giả